Harvard Bioscience, Inc.: shareholders and insiders

HBIONASDAQHealthcare · Laboratory Analytical Instruments

Price

$8.68

November 19, 2026Market cap $39M

What Ploutos Investor adds for Harvard Bioscience

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from 2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

Insiders and their shares

Purchases and sales by officers and directors from Nov 20, 2025 to Jun 12, 2026, from their own Form 4 filings.

5 Form 4s

Bought on the market

$202.4K

4 people

Sold on the market

–

nobody

From Nov 20, 2025 to Nov 20, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

No sales in the period.

  • Jun 9, 2026Katherine A. EadeDirector
    Kind
  • Jun 9, 2026William SniderDirector
    Kind
  • Jun 9, 2026Stephen J DenelskyDirector
    Kind
  • Jun 9, 2026Robert E. GagnonDirector
    Kind
  • Jun 9, 2026Seth Benjamin BensonDirector
    Kind
  • Mar 17, 2026William Snider
    Kind
  • Mar 17, 2026Stephen J Denelsky
    Kind
  • Mar 16, 2026Mark T FrostChief Financial Officer
    Kind
  • Mar 16, 2026William Snider
    Kind
  • Mar 16, 2026John D DukeChief Executive Officer
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 11, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by HBIO's officers and directors from 2006 up to November 19, 2025, 20 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%1 On a 13DSep 22, 2026 Latest filing
  • BroadOak Income Fund, L.P.with 3 more persons
    Share of class16.0%
  • Weber Capital Management, LLC
    Share of class7.26%
  • Leviticus Partners LP
    Share of class5.20%

What the holders on a 13D state as their purpose

From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.

  • BroadOak Income Fund, L.P.16.0%From the filing of Mar 23, 2026

    The information contained above in Item 1 and Item 3 of this Schedule 13D is incorporated herein by reference. The Reporting Persons acquired the securities of the Issuer in connection with the Loan Agreement. Mr. Snider serves a member of the board of directors of the Issuer and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Mr. Snider is a partner of BroadOak Capital Partners and manager of BroadOak Income Fund and BroadOak Fund VI. Subject to the Issuer's Insider Trading Policy and other applicable policies, Mr. Snider may from time to…

    From the filing of Mar 23, 2026
Fell to 5% or less (3)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • BlackRock, Inc.2.50%Jul 17, 202513G/A
  • Harvey Partners4.96%May 15, 202513G/A
  • Punch & Associates Investment Management, Inc.0.10%Apr 7, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Citadel Advisors (Griffin)
    In the quarter+87%
  • Millennium Mgmt (Englander)
    In the quarter-17%
  • Renaissance Technologies
    In the quarter-5.0%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 1.12% of its shares outstanding were held short, +11.5% since the report before.

Shares held short
50.2K
1.12%
Since the report before45.0K on Sep 30, 2026
+11.5%
3.2
15.9K
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 1.01M
  • Nov 15, 2023: Shares held short 1.07M
  • Nov 30, 2023: Shares held short 954.6K
  • Dec 15, 2023: Shares held short 881.9K
  • Dec 29, 2023: Shares held short 909.5K
  • Jan 12, 2024: Shares held short 865.5K
  • Jan 31, 2024: Shares held short 789.4K
  • Feb 15, 2024: Shares held short 738.3K
  • Feb 29, 2024: Shares held short 712.9K
  • Mar 15, 2024: Shares held short 716.6K
  • Mar 28, 2024: Shares held short 636.7K
  • Apr 15, 2024: Shares held short 673.0K
  • Apr 30, 2024: Shares held short 681.2K
  • May 15, 2024: Shares held short 620.1K
  • May 31, 2024: Shares held short 461.5K
  • Jun 14, 2024: Shares held short 386.2K
  • Jun 28, 2024: Shares held short 534.4K
  • Jul 15, 2024: Shares held short 430.7K
  • Jul 31, 2024: Shares held short 446.5K
  • Aug 15, 2024: Shares held short 426.8K
  • Aug 30, 2024: Shares held short 426.6K
  • Sep 13, 2024: Shares held short 429.1K
  • Sep 30, 2024: Shares held short 314.7K
  • Oct 15, 2024: Shares held short 350.6K
  • Oct 31, 2024: Shares held short 398.8K
  • Nov 15, 2024: Shares held short 374.1K
  • Nov 29, 2024: Shares held short 450.1K
  • Dec 13, 2024: Shares held short 533.1K
  • Dec 31, 2024: Shares held short 654.4K
  • Jan 15, 2025: Shares held short 785.1K
  • Jan 31, 2025: Shares held short 758.6K
  • Feb 14, 2025: Shares held short 906.6K
  • Feb 28, 2025: Shares held short 964.4K
  • Mar 14, 2025: Shares held short 1.05M
  • Mar 31, 2025: Shares held short 1.05M
  • Apr 15, 2025: Shares held short 1.06M
  • Apr 30, 2025: Shares held short 1.28M
  • May 15, 2025: Shares held short 1.96M
  • May 30, 2025: Shares held short 6.64M
  • Jun 13, 2025: Shares held short 2.83M
  • Jun 30, 2025: Shares held short 1.63M
  • Jul 15, 2025: Shares held short 1.16M
  • Jul 31, 2025: Shares held short 1.32M
  • Aug 15, 2025: Shares held short 592.2K
  • Aug 29, 2025: Shares held short 757.3K
  • Sep 15, 2025: Shares held short 657.2K
  • Sep 30, 2025: Shares held short 681.4K
  • Oct 15, 2025: Shares held short 579.9K
  • Oct 31, 2025: Shares held short 7.05M
  • Nov 14, 2025: Shares held short 1.38M
  • Nov 28, 2025: Shares held short 477.3K
  • Dec 15, 2025: Shares held short 586.4K
  • Dec 31, 2025: Shares held short 445.3K
  • Jan 15, 2026: Shares held short 434.8K
  • Jan 30, 2026: Shares held short 585.1K
  • Feb 13, 2026: Shares held short 670.3K
  • Feb 27, 2026: Shares held short 453.7K
  • Mar 13, 2026: Shares held short 473.1K
  • Mar 31, 2026: Shares held short 84.8K
  • Apr 15, 2026: Shares held short 243.5K
  • Apr 30, 2026: Shares held short 170.7K
  • May 15, 2026: Shares held short 120.9K
  • May 29, 2026: Shares held short 106.2K
  • Jun 15, 2026: Shares held short 89.3K
  • Jun 30, 2026: Shares held short 70.9K
  • Jul 15, 2026: Shares held short 56.0K
  • Jul 31, 2026: Shares held short 61.4K
  • Aug 14, 2026: Shares held short 58.8K
  • Aug 31, 2026: Shares held short 48.5K
  • Sep 15, 2026: Shares held short 48.1K
  • Sep 30, 2026: Shares held short 45.0K
  • Oct 15, 2026: Shares held short 50.2K

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading45.0% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 45.0% of the shares in the reported trades were short sales, against 34.4% in the 14 before.

Last 14 sessionsNov 2, 2026 – Nov 19, 2026
45.0%
The 14 beforeOct 13, 2026 – Oct 30, 2026
34.4%
Change
+10.6 pts
Short sales a dayon average, of 19.2K shares
8,634
More than atof 3,666 US-listed companies, same days
32%
Median of alleight in ten from 34.5% to 63.8%
50.4%
  • Oct 13, 2026: Short sales 5.1%
  • Oct 14, 2026: Short sales 24.8%
  • Oct 15, 2026: Short sales 20.8%
  • Oct 16, 2026: Short sales 24.9%
  • Oct 19, 2026: Short sales 23.5%
  • Oct 20, 2026: Short sales 35.6%
  • Oct 21, 2026: Short sales 77.3%
  • Oct 22, 2026: Short sales 37.5%
  • Oct 23, 2026: Short sales 32.8%
  • Oct 26, 2026: Short sales 24.4%
  • Oct 27, 2026: Short sales 22.7%
  • Oct 28, 2026: Short sales 44.7%
  • Oct 29, 2026: Short sales 49.3%
  • Oct 30, 2026: Short sales 27.3%
  • Nov 2, 2026: Short sales 37.5%
  • Nov 3, 2026: Short sales 40.9%
  • Nov 4, 2026: Short sales 52.5%
  • Nov 5, 2026: Short sales 68%
  • Nov 6, 2026: Short sales 31.4%
  • Nov 9, 2026: Short sales 74.6%
  • Nov 10, 2026: Short sales 41.7%
  • Nov 11, 2026: Short sales 47.7%
  • Nov 12, 2026: Short sales 29.9%
  • Nov 13, 2026: Short sales 37.5%
  • Nov 16, 2026: Short sales 18.8%
  • Nov 17, 2026: Short sales 32.4%
  • Nov 18, 2026: Short sales 14.2%
  • Nov 19, 2026: Short sales 8.8%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

3.43M Insiders' shares7.68% Of the company
  • James W GreenChief Executive Officer
    Directly3.11M
  • John D DukeChief Executive Officer
    Directly105.0K
  • Katherine A. EadeDirector
    Directly58.7K
  • William SniderDirector
    Directly48.6K
  • Stephen J DenelskyDirector
    Directly37.6K
  • Robert E. GagnonDirector
    Directly27.6K
  • Seth Benjamin BensonDirector
    Directly27.6K
  • Mark T FrostChief Financial Officer
    Directly17.5K

A lower bound: it counts only the 8 officers and directors with a market trade since Nov 21, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

2 ETFs holding it0.00% The largest weight (VXF)
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.00%
  • DFASDimensional U.S. Small Cap ETF
    Weight in the fund0.00%

2 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

37 Managers, Q2 2026$10M Value of their positions
  • Q3 2025: Managers 61
  • Q4 2025: Managers 64
  • Q1 2026: Managers 38
  • Q2 2026: Managers 37

Institutional investors by quarter

The fund managers holding HBIO, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 37 managers held 1.68M shares, worth $10M. During the quarter 4 opened a position, 5 closed one, 5 added and 15 trimmed.

The largest holders, Q2 2026

  • Weber Capital Management
    In the quarter-2.9%
  • Meros Investment Management
    In the quarter+54%
  • Acadian Asset Management
    In the quarter
  • Vanguard Capital Management
    In the quarter+3.9%
  • Nano Cap New Millennium Growth Fund L P
    In the quarter+22%
  • Corsair Capital Management
    In the quarter-1.6%
  • Two Sigma Investments
    In the quarter+0.4%
  • Renaissance Technologies
    In the quarter-2.1%
  • BlackRock
    In the quarter-0.6%
  • Geode Capital Management
    In the quarter-20%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Harvard Bioscience's filings show?

Who buys and sells is one part of Harvard Bioscience's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about HBIO's shareholders

Didn't find what you were looking for?

Ask us
Have HBIO's insiders bought or sold?

From Jun 11, 2026 to Jun 12, 2026 Harvard Bioscience's insiders reported no purchase or sale of shares on the market.

Which well-known managers hold HBIO?

3 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $700.0K.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.